It is not for self-administration
[DOI] [PubMed] [Google Scholar] 65.Zhao J.V., et al
Physical inactivity Physical inactivity is a common behavioral characteristic in individuals with depression, significantly contributing to the risk of developing T2DM [38]

In experimental systems, it has been examined for its influence on multiple physiological processes relevant to energy balance : Glucose regulation : Studied for glucose-dependent stimulation of insulin secretion and suppression of glucagon release Gastrointestinal function : Investigated for delayed gastric emptying and altered gastrointestinal motility Energy intake and body weight : Evaluated in large phase 2 and 3 research programs, including the STEP (SemaglutidE Treatment Effect in People with obesity) trial series Cardiometabolic markers : Examined for changes in blood pressure, lipid parameters, and inflammatory biomarkers Renal and hepatic endpoints : Explored as secondary or exploratory outcomes in selected studies Within laboratory environments, Semaglutide (20 mg) is commonly used for: In vitro GLP-1 receptor signaling assays Pancreatic islet and -cell biology studies Preclinical models of food intake and body-weight regulation Formulation, stability, and delivery-technology research All applications remain investigational and are conducted under controlled research conditions

Additionally, monitoring your progress through regular weigh-ins, tracking energy levels, and reassessing your approach every 36 months helps you identify early warning signs of weight regain and adjust your strategy before significant rebound occurs
Why the FDA Cautions Against Semaglutide in Pregnancy The FDAs caution around Semaglutide in pregnancy mainly stems from data collected during animal studies